High CX3CR1 expression predicts poor prognosis in paediatric acute myeloid leukaemia undergoing hyperleukocytosis.
Nan MeiHong SuSha GongHanzhi DuXiaojuan ZhangLu WangHuaiyu WangPublished in: International journal of laboratory hematology (2022)
Elevated CX3CR1 expression may be an adverse prognostic indicator in paediatric AML patients undergoing hyperleukocytosis. Moreover, CX3CR1 may serve as an immunotherapeutic target for AML with hyperleukocytosis in children.